Deschloroclotizolam
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| Chemical and physical data | |
| Formula | C15H11ClN4S |
| Molar mass | 314.79 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Deschloroclotizolam is a thienotriazolodiazepine derivative which has been sold as a designer drug, first being identified in Sweden in 2021.